Antitumor Activity of the New Bcl-2/Bcl-xl Inhibitor S44563 in Primary Human Uveal Melanoma Xenografts

被引:0
|
作者
Decaudin, D. [1 ]
Nemati, F. [1 ]
De Montrion, C. [2 ]
Lang, G. [1 ]
Sastre, X. [3 ]
Berthier, L. Kraus [2 ]
Dahmani, A. [1 ]
Desjardins, L. [4 ]
Piperno-Neumann, S. [5 ]
Depil, S. [2 ]
机构
[1] Inst Curie, Lab Preclin Invest, Paris 05, France
[2] Servier Labs, Suresnes, France
[3] Inst Curie, Dpt Tumor Biol, Paris 05, France
[4] Inst Curie, Dpt Ophthalmol, Paris 05, France
[5] Inst Curie, Dpt Med Oncol, Paris 05, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
777
引用
收藏
页码:S185 / S185
页数:1
相关论文
共 50 条
  • [31] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
    Chauhan, D.
    Velankar, M.
    Brahmandam, M.
    Hideshima, T.
    Podar, K.
    Richardson, P.
    Schlossman, R.
    Ghobrial, I.
    Raje, N.
    Munshi, N.
    Anderson, K. C.
    ONCOGENE, 2007, 26 (16) : 2374 - 2380
  • [32] BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
    Lee, Erinna F.
    Harris, Tiffany J.
    Tran, Sharon
    Evangelista, Marco
    Arulananda, Surein
    John, Thomas
    Ramnac, Celeste
    Hobbs, Chloe
    Zhu, Haoran
    Gunasingh, Gency
    Segal, David
    Behren, Andreas
    Cebon, Jonathan
    Dobrovic, Alexander
    Mariadason, John M.
    Strasser, Andreas
    Rohrbeck, Leona
    Haass, Nikolas K.
    Herold, Marco J.
    Fairlie, W. Douglas
    CELL DEATH & DISEASE, 2019, 10
  • [33] Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages
    Olie, RA
    Hafner, C
    Küttel, R
    Sigrist, B
    Willers, J
    Dummer, R
    Hall, J
    Stahel, RA
    Zangemeister-Wittke, U
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (03) : 505 - 512
  • [34] A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
    D Chauhan
    M Velankar
    M Brahmandam
    T Hideshima
    K Podar
    P Richardson
    R Schlossman
    I Ghobrial
    N Raje
    N Munshi
    K C Anderson
    Oncogene, 2007, 26 : 2374 - 2380
  • [35] Importance of functional groups in predicting the activity of small molecule inhibitors for Bcl-2 and Bcl-xL
    Kanakaveti, Vishnupriya
    Sakthivel, Ramasamy
    Rayala, S. K.
    Gromiha, M. Michael
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (02) : 308 - 316
  • [36] Functional effects of the Bcl-2/Bcl-xL inhibitor ABT-737 on primary cells from smoldering multiple myeloma
    Ricciardi, Maria Rosaria
    Calabrese, Elisabetta
    De Cave, Fabiana
    Santinelli, Sara
    Bergamo, Paola
    Decandia, Samantha
    Gregorj, Chiara
    Federico, Vincenzo
    Milella, Michele
    Foa, Robert
    Tafuri, Agostino
    Petrucci, Maria Teresa
    BLOOD, 2007, 110 (11) : 269B - 269B
  • [37] Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity
    Lv, Dongwen
    Pal, Pratik
    Liu, Xingui
    Jia, Yannan
    Thummuri, Dinesh
    Zhang, Peiyi
    Hu, Wanyi
    Pei, Jing
    Zhang, Qi
    Zhou, Shuo
    Khan, Sajid
    Zhang, Xuan
    Hua, Nan
    Yang, Qingping
    Arango, Sebastian
    Zhang, Weizhou
    Nayak, Digant
    Olsen, Shaun K.
    Weintraub, Susan T.
    Hromas, Robert
    Konopleva, Marina
    Yuan, Yaxia
    Zheng, Guangrong
    Zhou, Daohong
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [38] Antitumor Activity of Dual BCL-2/BCL-Xl Inhibitor Pelcitoclax (APG-1252) in Natural Killer/T-Cell Lymphoma (NK/TCL)
    Wang, Guangfeng
    Liang, Eric
    Ming, Ping
    Rui, Li
    Tang, Chunyang
    Lv, Jing
    Ge, Yangfeng
    Zhang, Fei
    Wang, Lvcheng
    Shang, Jingjin
    Yang, Dajun
    Zhai, Yifan
    BLOOD, 2021, 138
  • [39] Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction
    B Bailly-Maitre
    G de Sousa
    K Boulukos
    J Gugenheim
    R Rahmani
    Cell Death & Differentiation, 2001, 8 : 279 - 288
  • [40] The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells
    Allaman-Pillet, Nathalie
    Oberson, Anne
    Munier, Francis
    Schorderet, Daniel F.
    OPHTHALMIC GENETICS, 2013, 34 (1-2) : 1 - 13